The American Journal of Managed Care Partners with the Joslin Diabetes Center

June 4, 2012

The American Journal of Managed Care Partners with the Joslin Diabetes Center

The American Journal of Managed Care Will Serve as the Primary Post-Conference Consort for Joslin’s Diabetes Innovation 2012

Plainsboro, NJ - The American Journal of Managed Care announced today its partnership with Joslin Diabetes Center’s Diabetes Innovation 2012. As the exclusive post-conference media source of Diabetes Innovation 2012, The American Journal of Managed Care will focus on providing its audience pivotal information directly from the conference, which will take place September 23-25, 2012, near Washington DC.

According to Julie A. Brown, Director, Joslin Professional Education, “Diabetes Innovation 2012 is exactly the ‘prescription’ for an enormous problem—the dual epidemic of obesity and diabetes in the United States. By bringing together leaders from all stakeholder groups—public and private purchasers, payers, providers, industry, government, food manufacturers, research, finance, technology, and of course the patient—Diabetes Innovation 2012 will act as a catalyst for ideas, partnerships, and collaboration to provoke innovation and action that addresses the enormous cost, productivity, and quality of life impact of diabetes on our society.”

The American Journal of Managed Care will help to enhance the multimedia footprint of this novel conference by continuing its effort to deliver information relevant to clinical decision making in a cost-constrained environment while examining the impact of clinical, management, and policy programs on healthcare and economic outcomes. The post-conference media and analytics support provided by The American Journal of Managed Care will help to ensure that the findings and proceeds of this important event will be widely disseminated in order to engage the maximum number of stakeholders in innovative programs and initiatives that are underway or will be initiated.

“We are very excited to forge this new partnership with Joslin Diabetes Center and address the payers’ needs to preserve quality while tackling the increasing costs attached to this growing epidemic,” said Brian Haug, President, The American Journal of Managed Care. “This is an exciting undertaking and we are proud to be partnering with such a well-known and respected institution.”

Brown continued, “Through Diabetes Innovation 2012, we issue a challenge to each and every stakeholder to be the catalyst for new partnerships, practical and affordable solutions, and hope in our common goal of a future without diabetes or its complications. We are grateful to The American Journal of Managed Care for stepping up to help us meet this challenge.”

About The American Journal of Managed Care

The American Journal of Managed Care is an independent, peer-reviewed publication dedicated to publishing original research in healthcare outcomes and creating a forum for scientific communication in the ever-evolving field of healthcare delivery. The journal is indexed in MEDLINE/PUBMED. AJMC is published by the Intellisphere Managed Market Group, which is owned by MJH & Associates. For more information, please contact Tobin Sharp, Group Editorial Director, The American Journal of Managed Care, at 609.716.7777 or tsharp@ajmc.com.

About Joslin Diabetes Center

Joslin Diabetes Center, located in Boston, Massachusetts, is the world’s largest diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School.

Diabetes Innovation 2012 (www.diabetesinnovation.org) is the first ever national convening event sponsored by Joslin in its more than 100-year history. The 3-day event will feature an extensive faculty of nearly 70 thought leaders representing all stakeholders and an audience of delegates from all sectors who seek to lead in the effort to address the most important issues of today in the prevention and treatment of diabetes, as well as its comorbidities and complications.